<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">ZOLPIDEM <img border="0" src="../images/pr.gif"/></span><br/>(zol'-pi-dem)<br/><span class="topboxtradename">Ambien, Ambien CR<br/></span><b>Classifications:</b> <span class="classification">central nervous system agent</span>; <span class="classification">anxiolytic</span>; <span class="classification">sedative-hypnotic, non-benzodiazepine</span><br/><b>Pregnancy Category: </b>B<br/><b>Controlled Substance: </b>Schedule IV<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>5 mg, 10 mg tablets; 6.25 mg, 12.5 mg extended-release tablets</p>
<h1><a name="action">Actions</a></h1>
<p>Nonbenzodiazepine hypnotic. Does not have muscle relaxant or anticonvulsant effects.</p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Preserves deep sleep (stages 3 and 4) at hypnotic doses.</p>
<h1><a name="uses">Uses</a></h1>
<p>Short-term treatment of insomnia.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Lactation.</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Depressed patients, hepatic/renal impairment, older adults, pregnancy (category B), patients with compromised respiratory
         status. Safety and efficacy in children 
      </p><h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Short-Term Treatment of Insomnia</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 510 mg h.s. limited to 710 d<br/><span class="rdage">Geriatric:</span> <span class="rdroute">PO</span> Start with 5 mg h.s. limited to 710 d<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give immediately before bedtime; for more rapid sleep onset, do <small>NOT</small> give with or immediately after a meal.
         </li>
<li>Extended-release tablets should be swallowed whole. Ensure that they are not crushed or chewed.</li>
<li>Use reduced dosage of 5 mg in older adult or debilitated patients.</li>
<li>Store at room temperature, 15°30° C (59°86° F).</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span> Headache on awakening, drowsiness or fatigue, lethargy, drugged feeling, depression, anxiety, irritability, dizziness, double
      vision. Confusion and falls reported in elderly. Doses &gt;10 mg may be associated with anterograde amnesia or memory impairment.
       <span class="typehead">GI:</span> Dyspepsia, nausea, vomiting. <span class="typehead">Other:</span> Myalgia. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span>
<span class="classification">cns depressants</span>, <b>alcohol,</b>
<span class="classification">phenothiazines</span> by augmenting CNS depression. <span class="typehead">Food:</span> Extent and rate of absorption of zolpidem are significantly decreased. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Readily absorbed from GI tract. 70% reaches systemic circulation. Food decreases rate and extent of absorption. <span class="typehead">Onset:</span> 727 min. <span class="typehead">Peak:</span> 0.52.3h. <span class="typehead">Duration:</span> 68 h. <span class="typehead">Distribution:</span> Highly protein bound. Lowest concentrations in CNS, highest concentrations in glandular tissue and fat. Crosses placenta,
      very small amounts (Metabolism: Metabolized in the liver to 3 inactive metabolites. <span class="typehead">Elimination:</span> 7996% of dose appears as metabolites in the bile, urine, and feces. <span class="typehead">Half-Life:</span> 1.72.5 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Assess respiratory function in patients with compromised respiratory status. Report immediately to physician significantly
            depressed respiratory rate (less than 12/min).
         </li>
<li>Monitor patients for S&amp;S of depression (see Appendix F); zolpidem may increase level of depression.</li>
<li>Monitor older adult or debilitated patients closely for impaired cognitive or motor function and unusual sensitivity to the
            drug's effects.
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Avoid taking alcohol or other CNS depressants while on zolpidem.</li>
<li>Do not drive or engage in other potentially hazardous activities until response to drug is known.</li>
<li>Report vision changes to physician.</li>
<li>
            							Note: Onset of drug is more rapid when taken on an empty stomach.
            						
         </li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>